"Inflammation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Descriptor ID |
D007249
|
MeSH Number(s) |
C23.550.470
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation".
Below are MeSH descriptors whose meaning is more specific than "Inflammation".
This graph shows the total number of publications written about "Inflammation" by people in this website by year, and whether "Inflammation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 1 | 3 |
1996 | 0 | 5 | 5 |
1997 | 0 | 3 | 3 |
1998 | 0 | 6 | 6 |
1999 | 2 | 2 | 4 |
2000 | 1 | 4 | 5 |
2001 | 2 | 5 | 7 |
2002 | 5 | 8 | 13 |
2003 | 2 | 12 | 14 |
2004 | 10 | 11 | 21 |
2005 | 10 | 16 | 26 |
2006 | 11 | 22 | 33 |
2007 | 13 | 20 | 33 |
2008 | 7 | 13 | 20 |
2009 | 16 | 13 | 29 |
2010 | 12 | 14 | 26 |
2011 | 26 | 25 | 51 |
2012 | 15 | 28 | 43 |
2013 | 14 | 26 | 40 |
2014 | 20 | 22 | 42 |
2015 | 19 | 27 | 46 |
2016 | 16 | 32 | 48 |
2017 | 21 | 25 | 46 |
2018 | 28 | 30 | 58 |
2019 | 14 | 32 | 46 |
2020 | 29 | 43 | 72 |
2021 | 17 | 47 | 64 |
2022 | 4 | 56 | 60 |
2023 | 1 | 55 | 56 |
2024 | 10 | 19 | 29 |
2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation" by people in Profiles.
-
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut. 2025 Mar 06; 74(4):586-602.
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.
-
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol. 2025 Mar; 45(3):372-385.
-
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup. Sci Transl Med. 2025 Jan; 17(779):eadr2012.
-
[VEXAS-like auto inflammatory syndrome: 2?cases]. Rev Med Interne. 2025 Mar; 46(3):139-145.
-
Associations of systemic immune-inflammation index and systemic inflammation response index with maternal gestational diabetes mellitus: Evidence from a prospective birth cohort study. Chin Med J (Engl). 2025 Mar 20; 138(6):729-737.
-
Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment. Cancer Immunol Res. 2024 Dec 03; 12(12):1736-1752.
-
Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes. Proc Natl Acad Sci U S A. 2024 Dec 03; 121(49):e2401968121.
-
High Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies. Cells. 2024 Nov 23; 13(23).
-
Increased Pretransplant Inflammatory Biomarkers Predict Death With Function After Kidney Transplantation. Transplantation. 2024 Dec 01; 108(12):2434-2445.